How to buy Humana (HUM) stocks

Humana is a healthcare plans business based in the US. Humana shares (HUM) are listed on the NYSE and all prices are listed in US Dollars.

Its last market close was $247.10 – a decrease of 9.86% over the previous week. Humana employs 67,600 staff and has a trailing 12-month revenue of around $115 billion.

Our top picks for where to buy Humana stock

Buy Humana stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

Finder Score for stock trading platforms

To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score the better the platform - simple.

Read the full methodology

Related: Compare the best stock trading platforms in Canada

Humana stock price (NYSE: HUM)

Use our graph to track the performance of HUM stocks over time.

Humana stocks at a glance

• Key figures

Information last updated 2024-12-18.

Latest market close	$247.10
52-week range	$213.31 - $471.33
50-day moving average more info button	$273.33
200-day moving average more info button	$325.95
Wall St. target price	$288.80
PE ratio more info button	20.9293
Dividend yield more info button	$3.54 (1.48%)
Earnings per share (TTM) more info button	$11.46

Is it a good time to buy Humana stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Dive deeper: Our picks for the best stocks to buy right now in Canada

Humana price performance over time

Historical closes compared with the close of $247.1 from 2024-12-20

1 week (2024-12-13)	-9.86%
1 month (2024-11-22)	-17.11%
3 months (2024-09-20)	-20.40%
6 months (2024-06-21)	-30.49%

1 year (2023-12-22)	-45.48%
2 years (2022-12-22)	-50.96%
3 years (2021-12-22)	445.4703
5 years (2019-12-20)	355.4646

Is Humana stock undervalued or overvalued?

Valuing Humana stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Humana's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Humana's P/E ratio

Humana's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 21x. In other words, Humana shares trade at around 21x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the stock or simply that they're under-valued.

Humana's PEG ratio

Humana's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.072. A low ratio can be interpreted as meaning the stocks offer better value, while a higher ratio can be interpreted as meaning the stocks offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Humana's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.

Humana's EBITDA

Humana's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.8 billion.

The EBITDA is a measure of a Humana's overall financial performance and is widely used to measure a its profitability.

Humana financials

Revenue TTM	$115 billion
Operating margin TTM	2.66%
Gross profit TTM	$17.2 billion
Return on assets TTM	4.01%
Return on equity TTM	7.84%
Profit margin	1.18%
Book value	$145.88
Market Capitalization more info button	$28.9 billion

TTM: trailing 12 months

Humana stock dividends

Dividend payout ratio: 19.41% of net profits

Recently Humana has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Humana shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Humana's case, that would currently equate to about $3.54 per share.

While Humana's payout ratio might seem low, this can signify that Humana is investing more in its future growth.

Humana's most recent dividend payout was on 30 January 2025. The latest dividend was paid out to all shareholders who bought their stocks by 30 December 2024 (the "ex-dividend date").

Have Humana's stocks ever split?

Humana's stocks were split on a 3:2 basis on 31 July 1991 . So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Humana stocks – just the quantity. However, indirectly, the new 33.3% lower stock price could have impacted the market appetite for Humana stocks, which in turn could have impacted Humana's stock price.

Humana stock price volatility

Over the last 12 months, Humana's stocks have ranged in value from as little as $213.31 up to $471.3293. A popular way to gauge a stock's volatility is its "beta."

Beta is a measure of a stocks volatility in relation to the market. The market (NYSE average) beta is 1, while Humana's is 0.52. This would suggest that Humana's stocks are less volatile than average (for this exchange).

Humana overview

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties.

Related: New to stock trading? Compare brokers and get tips for investing.

Frequently asked questions

What percentage of Humana is owned by insiders or institutions?
Currently 0.203% of Humana stocks are held by insiders and 94.671% by institutions. How many people work for Humana?
Latest data suggests 67,600 work at Humana. When does the fiscal year end for Humana?
Humana's fiscal year ends in December. Where is Humana based?
Humana's address is: Humana Building, Louisville, KY, United States, 40202 What is Humana's ISIN number?
Humana's international securities identification number is: US4448591028 What is Humana's CUSIP number?
Humana's Committee on Uniform Securities Identification Procedures number is: 444859102

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.